Project

A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors

Ongoing - recruitment active · 2023 until 2026

Fischer Stefanie, Bürki Ramona, Quinter Janine